The effect and safety of the treatment of recurrent hepatitis C infection after orthotopic liver transplantation with pegylated interferon α2b and ribavirin

Transplantation Proceedings

Volumn 43, Issue 10, 2011, Pages 3824-3828

  Perrakis, A ^a   Yedibela, S ^a   Schuhmann, S ^a   Croner, R ^a   Schellerer, V ^a   Demir, R ^a   Hohenberger, W ^a   Mller, V ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; PEGINTERFERON ALPHA2B; PROTON PUMP INHIBITOR; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RIBAVIRIN; SILYMARIN; TACROLIMUS; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADULT; AGED; ANEMIA; ANTIVIRAL THERAPY; BIOCHEMICAL RESPONSE; CLINICAL ARTICLE; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GASTRITIS; GASTROINTESTINAL DISEASE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LEUKOPENIA; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; MEDICAL PARAMETERS; MYALGIA; NEUTROPENIA; PANCYTOPENIA; PRIORITY JOURNAL; RECURRENT DISEASE; STOMACH ULCER; SUSTAINED VIROLOGICAL RESPONSE; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VIROLOGICAL RESPONSE; VIRUS LOAD;

AGED; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; BIOPSY; DRUG THERAPY, COMBINATION; FEMALE; GERMANY; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RECURRENCE; RIBAVIRIN; RNA, VIRAL; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 83655180890     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.08.103     Document Type: Conference Paper

References (47)

1. A. Wasley, M.J. Alter Epidemiology of hepatitis C: geographic differences and temporal trends Semin Liver Dis 20 2000 1
2. L.B. Seeff Natural history of hepatitis C Hepatology 26 suppl 1 1997 215
3. T. Poynard, P. Bedossa, P. Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C The OBSVIRC, METAVIR, CLINNIR, and DOSVIRC groups Lancet 349 1997 825
4. G. Fattovich, G. Giustina, F. Degos Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients Gastroenterology 112 1997 463
5. A.M. Di Biscegile Hepatitis C and hepatocellular carcinoma Hepatology 26 suppl 1 1997 344
6. United Network for Organ Sharing OPTN data http://www.optn.org Accessed July 12, 2011
7. European Liver Transplant Registry ELTR data http.//www.eltr.org Accessed July 12, 2011
8. E. Gane, B.C. Portmann, N.V. Naoumov Long-term outcome of hepatitis C infection after liver transplantation N Engl J Med 334 1996 815
9. M. Prieto, M. Berenguer, J.M. Rajon High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes Hepatology 29 1999 250
10. R.M. Ghobrial Retransplantation for recurrent hepatitis C Liver Transpl 8 10 suppl 1 2002 S38
11. D. Samuel, C. Feray Recurrent hepatitis C after liver transplantation: clinical and therapeutical issues J Viral Hepat 7 2000 87
12. M. Berenguer, M. Prieto, F. San Juan Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients Hepatology 36 2002 202
13. L.M. Forman, J.D. Lewis, J.A. Berlin The association between hepatitis C infection and survival after orthotopic liver transplantation Gastroenterology 122 2002 889
14. R.G. Knodell, K.G. Ishak, W.C. Black Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology 1 1981 431
15. L. De Franceschi, G. Fattovich, F. Turrini Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage Hepatology 31 2000 997
16. M. Berenguer, M. Prieto, J.M. Rayon Natural history of clinically compensated HCV-related graft cirrhosis following liver transplantation Hepatology 32 2000 852
17. S. Yedibela, T. Fortsch, W. Hobenberger Liver transplantation for hepatocellular carcinoma: a single European centre experience Langenbecks Arch Surg 389 2004 104
18. E.J. Gane, S.K. Lo, S.M. Riordan A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation Hepatology 27 1998 1403
19. R. Quadri, E. Giostra, T. Roskamp Immunological and virological effects of ribavirin in hepatitis C after liver transplantation Transplantation 73 2002 373
20. T. Bizollon, U. Palazzo, C. Ducerf Pilot study of combination of interferon alpha and ribavirin as therapy of recurrent hepatitis C after liver transplantation Hepatology 26 1997 500
21. F. Zamboni, A. Franchello, B. Lavezzo Treatment of recurrent hepatitis C after liver transplantation with interferon alfa 2b and ribavirin [abstract] J Hepatol 32 suppl 1 2000 265
22. J. Ahmad, S.F. Dodson, A.J. Demetris Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin Liver Transpl 7 2001 863
23. A.B. Alberti, L.S. Belli, A. Airoldi Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study Liver Transpl 7 2001 870
24. M.E. De Vera, A.G. Smallwood, K. Rosado Interferon-α and ribavirin for the treatment of recurrent hepatitis C after liver transplantation Transplantation 71 2001 678
25. D. Samuel, T. Bizollon, C. Feray Combination interferon-alpha and ribavirin for recurrent HCV infection after liver transplantation: a randomized controlled study [abstract] Hepatology 32 2000 545
26. D. Samuel, T. Bizollon, C. Feray Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study Gastroenterology 124 2003 642
27. S. Mukherje, J. Rogge, L. Weaver Pilot study of pegylated interferon alpha-2b and ribavirin for recurrent hepatitis C after liver transplantation Transplant Proc 35 2003 3042
28. J. Dumortier, J.V. Scoazec, P. Chevallier Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alpha-2b and ribavirin combination J Hepatol 40 2004 669
29. A.S. Ross, A.K. Bhan, M. Pascul Pegylated interferon α-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C Clin Transpl 18 2004 166
30. M.W. Russo Antiviral therapy for hepatitis C is associated with improved clinical outcomes in patients with advanced fibrosis Expert Rev Gastroenterol Hepatol 4 2010 535
31. R.H. Wiesner, M. Sorrell, F. Villamil International Liver Transplantation Society Expert Panel Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C Liver Transpl 9 2003 S1
32. N. Chalasani, C. Manzarbeitia, P. Ferenci Pegasys Transplant Study Group Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials Hepatology 41 2005 289
33. T. Walter, J. Dumortier, O. Guillaud Rejection under alpha interferon therapy in liver transplant recipients Am J Transplant 7 2007 177
34. S. Yedibela, R. Demir, N. Melling Antiviral re-treatment of IFN-ribavirin non-responders for recurrent post-transplantation hepatitis C Clin Transplant 25 2010 131
35. C. Feray, D. Samuel, M. Gigou An open trial of interferon-α recombinant for hepatitis C after liver transplantation Hepatology 22 1995 1084
36. S. Yedibela, D. Schuppan, V. Mller Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation Liver Int 25 2005 717
37. D. Samuel, T. Bizollon, C. Feray Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study Gastroenterology 124 2003 642
38. I. Fernández, J.C. Meneu, F. Colina Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation Liver Transpl 12 2006 1805
39. P. Sharma, J.A. Marrero, R.J. Fontana Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence Liver Transpl 13 2007 1100
40. J.A. Carrión, M. Navasa, M. García-Retortillo Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study Gastroenterology 132 2007 1746
41. A.S. Ross, A.K. Bhan, M. Pascual Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C Clin Transplant 18 2004 166
42. S. Mukherjee, E. Lyden Impact of pegylated interferon alpha-2B and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series Liver Int 26 2006 529
43. S. Mukherjee, E. Lyden Impact of pegylated interferon alfa-2a and ribavirin on hepatic fibrosis inliver transplant patients with recurrent hepatitis C: an open-label series Hepatogastroenterology 53 2006 561
44. T. Bizollon, P. Pradat, J.Y. Mabrut Histological benefit of retreatment by pegylated interferon alfa-2b and ribavirin in patients with recurent hepatitis C virus infection posttransplantation Am J Transplant 7 2007 448
45. G.W. Neff, M. Montalbano, C.B. O'Brien Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy Transplantation 78 2004 1303
46. M.G. Rumi, A. Aghemo, G.M. Prati Randomized study of peginterferon- alpha2a plus ribavirin vs peginterferon-alpha2b plus ribavirin in chronic hepatitis C Gastroenterology 138 2010 108
47. P. Toniutto, C. Fabris, E. Fumo Pegylated versus standard interferon-alpha in antiviral regimens for post-transplant recurrent hepatitis C: Comparison of tolerability and efficacy J Gastroenterol Hepatol 20 2005 577